Clinical Trials Browser

sofosbuvir-velpatasvir drug combination × Clear all

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT04653818 2023-04-04

RCT

Phase 4 Completed

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Recurrence